294 related articles for article (PubMed ID: 15709031)
1. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.
Gillgrass AE; Tang VA; Towarnicki KM; Rosenthal KL; Kaushic C
J Virol; 2005 Mar; 79(5):3117-26. PubMed ID: 15709031
[TBL] [Abstract][Full Text] [Related]
2. Intranasal and subcutaneous immunization under the effect of estradiol leads to better protection against genital HSV-2 challenge compared to progesterone.
Bhavanam S; Snider DP; Kaushic C
Vaccine; 2008 Nov; 26(48):6165-72. PubMed ID: 18804503
[TBL] [Abstract][Full Text] [Related]
3. Estradiol limits viral replication following intravaginal immunization leading to diminished mucosal IgG response and non-sterile protection against genital herpes challenge.
Gillgrass A; Chege D; Bhavanam S; Kaushic C
Am J Reprod Immunol; 2010 Apr; 63(4):299-309. PubMed ID: 20070285
[TBL] [Abstract][Full Text] [Related]
4. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract.
Gallichan WS; Rosenthal KL
Virology; 1996 Oct; 224(2):487-97. PubMed ID: 8874509
[TBL] [Abstract][Full Text] [Related]
5. Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation.
Gillgrass AE; Fernandez SA; Rosenthal KL; Kaushic C
J Virol; 2005 Mar; 79(5):3107-16. PubMed ID: 15709030
[TBL] [Abstract][Full Text] [Related]
6. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2.
Kwant A; Rosenthal KL
Vaccine; 2004 Aug; 22(23-24):3098-104. PubMed ID: 15297061
[TBL] [Abstract][Full Text] [Related]
7. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2.
Gillgrass AE; Ashkar AA; Rosenthal KL; Kaushic C
J Virol; 2003 Sep; 77(18):9845-51. PubMed ID: 12941893
[TBL] [Abstract][Full Text] [Related]
8. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
[TBL] [Abstract][Full Text] [Related]
9. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
[TBL] [Abstract][Full Text] [Related]
10. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
Tengvall S; Harandi AM
J Reprod Immunol; 2008 Jun; 78(1):49-57. PubMed ID: 17945349
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of genital T cell responses to herpes simplex virus type 2 resulting from immunization of the nasal mucosa.
Milligan GN; Dudley-McClain KL; Chu CF; Young CG
Virology; 2004 Jan; 318(2):507-15. PubMed ID: 14972519
[TBL] [Abstract][Full Text] [Related]
12. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
Tengvall S; O'Hagan D; Harandi AM
Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
[TBL] [Abstract][Full Text] [Related]
13. Progesterone increases susceptibility and decreases immune responses to genital herpes infection.
Kaushic C; Ashkar AA; Reid LA; Rosenthal KL
J Virol; 2003 Apr; 77(8):4558-65. PubMed ID: 12663762
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with a HSV-2 UL24 mutant induces a protective immune response in murine and guinea pig vaginal infection models.
Visalli RJ; Natuk RJ; Kowalski J; Guo M; Blakeney S; Gangolli S; Cooper D
Vaccine; 2014 Mar; 32(12):1398-406. PubMed ID: 24462481
[TBL] [Abstract][Full Text] [Related]
15. Parameters of CpG oligodeoxynucleotide-induced protection against intravaginal HSV-2 challenge.
Sajic D; Ashkar AA; Patrick AJ; McCluskie MJ; Davis HL; Levine KL; Holl R; Rosenthal KL
J Med Virol; 2003 Dec; 71(4):561-8. PubMed ID: 14556270
[TBL] [Abstract][Full Text] [Related]
16. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
17. Delayed but effective induction of mucosal memory immune responses against genital HSV-2 in the absence of secondary lymphoid organs.
Roth KL; Bhavanam S; Jiang H; Gillgrass A; Ho K; Ferreira VH; Kaushic C
Mucosal Immunol; 2013 Jan; 6(1):56-68. PubMed ID: 22718264
[TBL] [Abstract][Full Text] [Related]
18. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2.
Parr EL; Parr MB
J Virol; 1997 Nov; 71(11):8109-15. PubMed ID: 9343160
[TBL] [Abstract][Full Text] [Related]
20. Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice.
Parr MB; Harriman GR; Parr EL
Immunology; 1998 Oct; 95(2):208-13. PubMed ID: 9824477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
